These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35670527)

  • 21. Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy.
    Kanagawa M; Toda T
    J Neuromuscul Dis; 2017; 4(4):259-267. PubMed ID: 29081423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy.
    Yagi H; Kuo CW; Obayashi T; Ninagawa S; Khoo KH; Kato K
    Mol Cell Proteomics; 2016 Nov; 15(11):3424-3434. PubMed ID: 27601598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.
    Cataldi MP; Lu P; Blaeser A; Lu QL
    Nat Commun; 2018 Aug; 9(1):3448. PubMed ID: 30150693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammalian O-mannosyl glycans: Biochemistry and glycopathology.
    Endo T
    Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(1):39-51. PubMed ID: 30643095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan.
    Praissman JL; Live DH; Wang S; Ramiah A; Chinoy ZS; Boons GJ; Moremen KW; Wells L
    Elife; 2014 Oct; 3():. PubMed ID: 25279697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
    Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
    Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model.
    Wu B; Drains M; Shah SN; Lu PJ; Leroy V; Killilee J; Rawls R; Tucker JD; Blaeser A; Lu QL
    PLoS One; 2022; 17(12):e0278482. PubMed ID: 36454905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan.
    Walimbe AS; Okuma H; Joseph S; Yang T; Yonekawa T; Hord JM; Venzke D; Anderson ME; Torelli S; Manzur A; Devereaux M; Cuellar M; Prouty S; Ocampo Landa S; Yu L; Xiao J; Dixon JE; Muntoni F; Campbell KP
    Elife; 2020 Sep; 9():. PubMed ID: 32975514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
    Patnaik SK; Stanley P
    J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation.
    Riemersma M; Froese DS; van Tol W; Engelke UF; Kopec J; van Scherpenzeel M; Ashikov A; Krojer T; von Delft F; Tessari M; Buczkowska A; Swiezewska E; Jae LT; Brummelkamp TR; Manya H; Endo T; van Bokhoven H; Yue WW; Lefeber DJ
    Chem Biol; 2015 Dec; 22(12):1643-52. PubMed ID: 26687144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
    Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
    Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle.
    Nilsson J; Nilsson J; Larson G; Grahn A
    Glycobiology; 2010 Sep; 20(9):1160-9. PubMed ID: 20507882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycobiology of α-dystroglycan and muscular dystrophy.
    Endo T
    J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosynthetic Mechanisms and Biological Significance of Glycerol Phosphate-Containing Glycan in Mammals.
    Imae R; Manya H; Endo T
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan.
    Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L
    Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi.
    Ury B; Potelle S; Caligiore F; Whorton MR; Bommer GT
    J Biol Chem; 2021; 296():100789. PubMed ID: 34015330
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.